Atria Investments Inc Sells 4,308 Shares of CVS Health Co. (NYSE:CVS)

Atria Investments Inc lessened its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 6.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 61,902 shares of the pharmacy operator's stock after selling 4,308 shares during the period. Atria Investments Inc's holdings in CVS Health were worth $2,779,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Widmann Financial Services Inc. raised its stake in CVS Health by 1.8% during the third quarter. Widmann Financial Services Inc. now owns 11,506 shares of the pharmacy operator's stock worth $724,000 after buying an additional 200 shares during the last quarter. Manchester Capital Management LLC raised its stake in CVS Health by 4.8% during the fourth quarter. Manchester Capital Management LLC now owns 4,457 shares of the pharmacy operator's stock worth $200,000 after buying an additional 204 shares during the last quarter. Rogco LP raised its stake in CVS Health by 3.2% during the fourth quarter. Rogco LP now owns 6,752 shares of the pharmacy operator's stock worth $303,000 after buying an additional 210 shares during the last quarter. Glass Jacobson Investment Advisors llc raised its stake in CVS Health by 26.8% during the third quarter. Glass Jacobson Investment Advisors llc now owns 1,220 shares of the pharmacy operator's stock worth $77,000 after buying an additional 258 shares during the last quarter. Finally, CKW Financial Group raised its stake in CVS Health by 9.1% during the fourth quarter. CKW Financial Group now owns 3,600 shares of the pharmacy operator's stock worth $162,000 after buying an additional 300 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Remove Ads

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Piper Sandler lowered their target price on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating for the company in a research note on Monday, November 25th. JPMorgan Chase & Co. lifted their price target on shares of CVS Health from $80.00 to $81.00 and gave the company an "overweight" rating in a research note on Tuesday, February 18th. TD Cowen lifted their price target on shares of CVS Health from $73.00 to $80.00 and gave the company a "buy" rating in a research note on Monday, November 25th. Royal Bank of Canada decreased their price target on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a research note on Friday, November 15th. Finally, Cantor Fitzgerald raised shares of CVS Health from a "neutral" rating to an "overweight" rating in a research note on Wednesday, February 12th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $69.83.

CVS Health Stock Up 1.7 %

CVS Health stock traded up $1.09 during midday trading on Friday, hitting $66.34. 10,082,148 shares of the stock were exchanged, compared to its average volume of 11,965,158. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The stock has a market capitalization of $83.64 billion, a price-to-earnings ratio of 18.12, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54. The business's 50-day moving average price is $56.42 and its 200-day moving average price is $56.75. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. On average, research analysts expect that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.01%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health's payout ratio is 72.68%.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Michael F. Mahoney purchased 30,000 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The shares were bought at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the purchase, the director now owns 39,356 shares of the company's stock, valued at $2,625,045.20. This represents a 320.65 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP James David Clark sold 7,513 shares of the company's stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the sale, the senior vice president now owns 8,394 shares in the company, valued at $556,941.90. The trade was a 47.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.24% of the company's stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.